| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Operating Officer | Senior Vice President | Senior Vice President
2 companies
Jean-Claude Kyrillos is EVP & Chief Operating Officer at TNDM and has filed Form 4s across 2 companies. Jean-Claude Kyrillos's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.3M at current prices.
The biggest single holding is NVST (~$690K) as Senior Vice President.
Jean-Claude Kyrillos has 21 Form 4 filings on record from February 2020 to October 2026, across 2 companies: EVP & Chief Operating Officer at Tandem Diabetes Care (TNDM), 2024–2026; Senior Vice President at Envista (NVST), 2020–2023.
The 40 reported transactions were 13 option or other derivative awards, 11 tax withholdings, 8 option exercises and 7 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $191K and no sales.
The only open-market purchase was 10,538 shares of TNDM at an average $18.12 on March 7, 2025, about $191K. Twelve months later TNDM was up 18%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | TNDM Tandem Diabetes Care Inc | EVP & Chief Operating Officer | Buy | 10,538 | $18.12 | $190,966.47 | New | +15.0% | +17.7% |